Gouty Arthritis Market Poised for 7.2 % Growth, Set to Hit $4.72 Billion by 2029

How Is the Gouty Arthritis Market Projected to Grow, and What Is Its Market Size?
The market for gouty arthritis has seen a robust expansion in the past years. The market size is predicted to increase from $3.44 billion in 2024 to $3.7 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The prior growth can be tied back to factors such as high occurrence of chronic diseases, elevated consumption of alcohol, growth in the aging population, increased adoption of advanced regeneration therapies, and an upsurge in healthcare spending.

The market size of gouty arthritis is anticipated to undergo meaningful expansion in the forthcoming years. A growth to $4.9 billion by 2029 is projected, corresponding to a compound annual growth rate (CAGR) of 7.2%. The expansion throughout the predicted period can be linked to enhancements in healthcare structure, escalation in obesity rates, a rise in gout occurrence, and heightened awareness among the populace. Key trends for the forecast period encompass the escalating demand for efficacious treatment methods, regenerative treatment therapies, advances in technology, introductions of new products, and approvals from regulatory bodies.

What Are the Main Catalysts for Growth in the Gouty Arthritis Market?
The continual rise in obesity rates is anticipated to fuel the expansion of the gouty arthritis market. Obesity, a health condition marked by excessive accumulation of body fat that endangers an individual's health, is often assessed using body mass index (BMI). The obesity rate is escalating due to the higher intake of high-calorie, processed foods and inactive lifestyles. Obesity augments the risk of gouty arthritis by elevating the production of uric acid while decreasing the body's capacity to eliminate it, resulting in uric acid crystal buildup in the joints. Moreover, added body weight exerts extra strain on joints, aggravating the inflammation and pain linked with gout. For example, in March 2022, the World Health Organization, a specialized agency of the United Nations based in Switzerland that oversees global public health, reported that about 1 billion people, including 650 million adults, 340 million teenagers, and 39 million children, were categorized as obese, and this figure is steadily increasing. The forecast suggests that by 2025, roughly 167 million adults and children will face health issues stemming from being overweight. Hence, the escalating prevalence of obesity is stimulating the growth of the gouty arthritis market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp

Who Are the Major Industry Players Fueling Gouty Arthritis Market Expansion?
Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.

Which Key Developments Are Influencing the Gouty Arthritis Market?
Leading businesses in the gouty arthritis market are intensifying their endeavors to invent innovative products like cortrophin gel, aimed at offering more accurate and potent treatments for controlling the disease. Cortrophin gel, or repository corticotropin injection as it is also known, is a refined variant of the adrenocorticotropic hormone (ACTH). It can be used to address a range of inflammatory and autoimmune disorders, such as gouty arthritis. For instance, in October 2023, ANI Pharmaceuticals, a pharmaceutical company based in the US, secured approval from the Food and Drug Administration to introduce a new 1 mL vial size of Purified Cortrophin Gel. The product is designed as an adjunctive treatment for certain patients suffering from acute flares of gouty arthritis. Currently, Cortrophin Gel is the lone FDA-approved adrenocorticotropic hormone (ACTH) therapy designed to treat suitable patients dealing with acute episodes of gouty arthritis.

How Is the Segmentation of the Gouty Arthritis Market Defined?
The gouty arthritis market covered in this report is segmented -

1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others Treatments
3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities
2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

What Is the Leading Region in the Gouty Arthritis Market?
North America was the largest region in the gouty arthritis market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Gouty Arthritis Global Market Report?

- Market Size Analysis: Analyze the Gouty Arthritis Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Gouty Arthritis Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Gouty Arthritis Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Gouty Arthritis Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16070

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.